Votes at a glance: policy committee records support recommendations on multiple health‑care bills

At its meeting the California State Board of Pharmacy policy committee took votes recommending board positions on a slate of legislative measures. Items where the committee recommended support (motion carried) include AB 18 54 (legally protected health‑care activities), AB 19 30 (limits on out‑of‑state inquiries regarding protected health care activity), AB 19 79 (artificial intelligence and clinical judgment, support if amended to extend protections to all practice sites), AB 2,000 (drug formulary change protections), AB 25 65 (Medi‑Cal pharmacist services reporting), AB 25 71 (reimbursement parity for advanced pharmacist practitioners), SB 9 15 (patients accompanied by immigration enforcement officers), SB 9 64 (prescription dose adjustments), SB 10 23 (antiretroviral drugs coverage), and SB 11 99 (drug cost sharing) among others. Several measures the committee decided to monitor or offer technical amendments on included SB 10 94 (biosimilar substitution) and SB 13 47 (school emergency albuterol inhalers). AB 19 90 (compounding and consumer protection) prompted the most substantive debate and public testimony and was left as 'watch' pending staff engagement with the author and stakeholders.

Where motions were recorded, the transcript shows a verbal roll call with members indicating 'yes' (and occasional abstentions noted); the committee chair returned control to the meeting president after each vote. Numeric vote tallies are recorded verbally in the meeting but were not provided as a summarized numeric roll call in the meeting transcript.